BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2409785)

  • 1. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G; Denis L
    Acta Urol Belg; 1985; 53(2):428-40. PubMed ID: 2409785
    [No Abstract]   [Full Text] [Related]  

  • 2. The chemotherapy of disseminated testicular non-seminomatous germ cell tumors and the clinical research of the EORTC Genitourinary Group.
    Stoter G
    Prog Clin Biol Res; 1985; 203():437-47. PubMed ID: 2421335
    [No Abstract]   [Full Text] [Related]  

  • 3. A multivariate analysis of prognostic factors in disseminated non-seminomatous testicular cancer.
    Stoter G; Sylvester R; Sleijfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M
    Prog Clin Biol Res; 1988; 269():381-93. PubMed ID: 2455909
    [No Abstract]   [Full Text] [Related]  

  • 4. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs).
    Pliarchopoulou K; Pectasides D
    Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor prognosis germ cell tumors of the testes: improved results with high dose regimens.
    Ozols RF
    Prog Clin Biol Res; 1988; 269():419-27. PubMed ID: 2455910
    [No Abstract]   [Full Text] [Related]  

  • 6. Experience with PVB in non seminomatous germ-cell cancer of the testis.
    Jacquillat C; Auclerc G; Auclerc MF; Verges J; Weil M
    Prog Clin Biol Res; 1985; 203():451-6. PubMed ID: 2421336
    [No Abstract]   [Full Text] [Related]  

  • 7. Poor-prognosis germ cell tumors: we have not yet crossed the finish line.
    Vaughn DJ; Stadtmauer EA
    J Clin Oncol; 2007 Jan; 25(3):239-40. PubMed ID: 17235039
    [No Abstract]   [Full Text] [Related]  

  • 8. Bleomycin in germ cell testicular tumors (GCTT).
    Germa Lluch JR
    Prog Clin Biol Res; 1985; 203():381-9. PubMed ID: 2421332
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemotherapeutic effectiveness in malignant testicular tumors at advanced stages. Preliminary results of the VAB VI program].
    Chiricuţă I; Ghilezan N
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir; 1985; 34(6):455-68. PubMed ID: 2421373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Carboplatin-etoposide-bleomycine chemotherapy protocol in the treatment of patients with metastatic non-seminomatous germ-cell testicular tumours with good prognosis].
    Jeremić B; Djurić Lj; Djordjević S; Cirović V; Milojević Lj; Stanisavljević B; Matović M; Mijatović Lj
    Srp Arh Celok Lek; 1994; 122(9-10):257-9. PubMed ID: 17977429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of stage III germinal testicular tumors.
    Akdaş A; Kirkali Z; Altuğ U; Ilker Y
    Turk J Pediatr; 1984; 26(1-4):301-6. PubMed ID: 6085662
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chemotherapy of disseminated germ cell tumors of the testis].
    Tiuliandin SA
    Sov Med; 1987; (11):78-81. PubMed ID: 2451298
    [No Abstract]   [Full Text] [Related]  

  • 13. Our experience in regard to the relationship between the size of retroperitoneal lymph node metastases and the effect of chemotherapy in non seminomatous germ cell tumors.
    Guazzieri S; Ferro G; Lembo A; Merlo F; Sperandio P; Pagano F
    Prog Clin Biol Res; 1985; 203():457-62. PubMed ID: 2421337
    [No Abstract]   [Full Text] [Related]  

  • 14. Selected use of aggressive adjuvant chemotherapy in resected stage II nonseminomatous germ cell tumors of the testis.
    Pizzocaro G
    Prog Clin Biol Res; 1985; 203():585-90. PubMed ID: 2421344
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of ifosfamide in the treatment of nonseminomatous testicular cancer.
    Scheulen ME; Niederle N; Kath R; Wandl UB; Seeber S; Schmidt CG
    Prog Clin Biol Res; 1988; 269():439-50. PubMed ID: 2455912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of VP 16 in the treatment of non-seminomatous germ cell tumors of the testis].
    Bassoulet J; Varette C; Pabot du Chatelard P; Guillemot MC; Joussemet M; Martoia R
    Therapie; 1988; 43(4):279-84. PubMed ID: 2847346
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleomycin in testicular cancer: will pharmacogenomics improve treatment regimens?
    Bokemeyer C
    J Clin Oncol; 2008 Apr; 26(11):1783-5. PubMed ID: 18398143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Raynaud's disease after treatment with bleomycin and vinblastine].
    Dzieza-Lalowicz I; Mykała-Cieśla J
    Pol Tyg Lek; 1986 Feb; 41(7):218-9. PubMed ID: 2423995
    [No Abstract]   [Full Text] [Related]  

  • 19. Chemotherapy for clinical stage I nonseminomatous germ cell tumours.
    Vaughn DJ
    BJU Int; 2009 Nov; 104(9 Pt B):1381-6. PubMed ID: 19840017
    [No Abstract]   [Full Text] [Related]  

  • 20. Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer.
    de Haas EC; Zwart N; Meijer C; Nuver J; Boezen HM; Suurmeijer AJ; Hoekstra HJ; van der Steege G; Sleijfer DT; Gietema JA
    J Clin Oncol; 2008 Apr; 26(11):1817-23. PubMed ID: 18398146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.